Epitomee Medical Ltd (TLV:EPIT)
Israel · Delayed Price · Currency is ILS · Price in ILA 441.00
+5.00 (1.15%)
Oct 1, 2026, 2:24 PM IDT
Epitomee Medical Market Cap
Epitomee Medical has a market cap or net worth of 130.6 million as of October 2, 2026. Its market cap has decreased by -45.00% in one year.
Market Cap
130.60M
Enterprise Value
122.52M
Revenue
2.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
441.00
ChartMarket Cap Chart
Since December 15, 2021, Epitomee Medical's market cap has decreased from 1.21B to 130.60M, a decrease of -89.17%. That is a compound annual growth rate of -37.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 130.60M | -28.33% |
| Dec 31, 2025 | 182.22M | -32.71% |
| Dec 31, 2024 | 270.81M | 149.63% |
| Dec 31, 2023 | 108.48M | -67.89% |
| Dec 29, 2022 | 337.85M | -63.70% |
| Dec 30, 2021 | 930.82M | -22.80% |
| Dec 15, 2021 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.55B |
| Amal Holdings A.D. | 2.23B |
| Rafa Laboratories | 1.75B |
| BrainsWay | 1.56B |
| Bonus BioGroup | 210.26M |
| InterCure | 200.07M |
| Golden House | 164.17M |
| Rekah Pharmaceutical Industry | 134.24M |